SGCB and cancer: In summary, we have discovered that sGC is a novel transcriptional target of TMPRSS2-ERG in PCa cells, and showed that the sGC-mediated NO-cGMP pathway was a critical downstream effector of ERG in promoting cancer cell proliferation and tumorigenesis.